@article{9c1a6a6998e64ad3aeb589372c7e1a17,
title = "Antibiotics for treatment of leptospirosis",
abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the beneficial and harmful effects of antibiotics versus placebo, no intervention, or another antibiotic for the treatment of people with leptospirosis.",
author = "Patrick Mukadi and Kozue Tabei and Tansy Edwards and Brett-Major, {David M.} and Chris Smith and Emi Kitashoji and Win, {Tin Zar}",
note = "Funding Information: This work is in part funded by Nagasaki University (salary support for CS, TW, and TE). Funding Information: The Cochrane Hepato-Biliary (CHB) Editorial Team supported the authors in the development of this review. The following people from the CHB Editorial Team conducted the editorial process for this article: Sign-off Editor (final editorial decision): Christian Gluud, Co-ordinating Editor Cochrane Hepato-Biliary Group, Denmark; Contact Editor (provided editorial decision): Joshua Feinberg, Denmark; Statistical Editor (commented on statistics): Giovanni Casazza, Department of Clinical Sciences and Community Health, Universit{\`a} degli Studi di Milano, Italy; Managing Editor (selected peer reviewers, provided editorial guidance to authors, edited the article): Dimitrinka Nikolova, Denmark; Information Specialist (database searches): Sarah Louise Klingenberg, Denmark; Peer-reviewers (provided clinical and content review comments): Christopher Parry, Liverpool School of Tropical Medicine, UK; Marta Ferreira Maia, KEMRI-Wellcome Trust Research Programme, Kenya; Cho Niang, James Cook University, Queensland, Australia; (Information Specialist review): Robin M Featherstone, Editorial & Methods Department, Cochrane Executive, London, UK; Associate Editor, Evidence Production and Methods Department, Cochrane: Rachel Richardson, UK; Copy Editor (copy editing and production): Anne Lawson, Copy Edit Support, Cochrane. Sign-off Editor (final editorial decision): Christian Gluud, Co-ordinating Editor Cochrane Hepato-Biliary Group, Denmark; Contact Editor (provided editorial decision): Joshua Feinberg, Denmark; Statistical Editor (commented on statistics): Giovanni Casazza, Department of Clinical Sciences and Community Health, Universit{\`a} degli Studi di Milano, Italy; Managing Editor (selected peer reviewers, provided editorial guidance to authors, edited the article): Dimitrinka Nikolova, Denmark; Information Specialist (database searches): Sarah Louise Klingenberg, Denmark; Peer-reviewers (provided clinical and content review comments): Christopher Parry, Liverpool School of Tropical Medicine, UK; Marta Ferreira Maia, KEMRI-Wellcome Trust Research Programme, Kenya; Cho Niang, James Cook University, Queensland, Australia; (Information Specialist review): Robin M Featherstone, Editorial & Methods Department, Cochrane Executive, London, UK; Associate Editor, Evidence Production and Methods Department, Cochrane: Rachel Richardson, UK; Copy Editor (copy editing and production): Anne Lawson, Copy Edit Support, Cochrane. Cochrane Review Group funding acknowledgement: the Danish State is the largest single funder of the Cochrane Hepato-Biliary Group through its investment in the Copenhagen Trial Unit, Centre for Clinical Intervention Research, the Capital Region, Rigshospitalet, Copenhagen, Denmark. Disclaimer: the views and opinions expressed in this protocol are those of the authors and do not necessarily reflect those of the Danish State or the Copenhagen Trial Unit. Publisher Copyright: Copyright {\textcopyright} 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",
year = "2022",
month = may,
day = "27",
doi = "10.1002/14651858.CD014960",
language = "English (US)",
volume = "2022",
journal = "Cochrane Database of Systematic Reviews",
issn = "1465-1858",
publisher = "John Wiley and Sons Ltd",
number = "5",
}